UK-US Drug Export Deal: NHS Faces Billions in Cost
Partnership spares British drug exports from Trump-era US tariffs but critics warn the arrangement costs NHS billions. Deal gives UK patients better access to life-extending treatments.
The angle
International trade with domestic health impact - shows how global deals affect everyday healthcare access.
Why it matters
Affects pharmaceutical pricing, patient treatment options, and reveals tensions between trade benefits and healthcare costs.
What to watch next
Read about ANC Youth League reshuffle conflict